Yingli Wu
- Molecular Biology top 5%
- Cancer Research top 5%
- Oncology top 5%
- Hematology top 5%
- Immunology top 10%
- Topics
- Ubiquitin and proteasome pathways (36 papers)Retinoids in leukemia and cellular processes (20 papers)Acute Myeloid Leukemia Research (15 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaThailandUnited States
In The Last Decade
Yingli Wu
142 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 2.2k
- Cancer Research 541
- Oncology 516
- Hematology 327
- Immunology 278
Countries citing papers authored by Yingli Wu
This map shows the geographic impact of Yingli Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingli Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingli Wu more than expected).
Fields of papers citing papers by Yingli Wu
This network shows the impact of papers produced by Yingli Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingli Wu. The network helps show where Yingli Wu may publish in the future.
Co-authorship network of co-authors of Yingli Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Yingli Wu. A scholar is included among the top collaborators of Yingli Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingli Wu. Yingli Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 50 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 9 | |
| 12 | 9 | |
| 13 | 22 | |
| 14 | 27 | |
| 15 | 12 | |
| 16 | 64 | |
| 17 | 13 | |
| 18 | 27 | |
| 19 | MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer | 3 |
| 20 | 40 |
About Yingli Wu
Yingli Wu is a scholar working on Hematology, Molecular Biology and Cancer Research, having authored 145 papers that have together received 3.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (36 papers), Retinoids in leukemia and cellular processes (20 papers) and Acute Myeloid Leukemia Research (15 papers). The work is most often cited by research in Cancer Research (541 citations), Molecular Biology (2.2k citations) and Hematology (327 citations). Yingli Wu has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Guoqiang Chen, Hanzhang Xu, Hu Lei, Chuanxu Liu, Feng‐Hou Gao, Wei‐Lie Xiao, Han‐Dong Sun, Weiwei Wang, Meng Zhao and Chunmin Ma. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.